# FDA Inspection 1087221 - Shandong Xinhua Pharmaceutical Company Limited - March 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/92338ae1-9f91-46e4-bd2c-776ae27f2a10
Source feed: FDA_Inspections

> FDA Inspection 1087221 for Shandong Xinhua Pharmaceutical Company Limited on March 29, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087221
- Company Name: Shandong Xinhua Pharmaceutical Company Limited
- Inspection Date: 2019-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1237492 - 2024-04-05](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/b51d6e0b-a536-4115-820a-9e478884c09c)
- [FDA Inspection 1087221 - 2019-03-29](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/8cabcfe8-ae79-4a6c-a609-014d0772be81)
- [FDA Inspection 997761 - 2016-03-31](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/b4b9957b-25e4-450b-91ef-6d6159f6ba3a)
- [FDA Inspection 876774 - 2014-04-04](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/a124a9af-f1c7-49e0-801f-9d58ab859df0)

Company: https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c